Enhancing epitope of PEDV spike protein

Enhancing epitope of PEDV spike protein

Porcine epidemic diarrhea virus (PEDV) is the causative agent of a highly contagious enteric disease of pigs characterized by diarrhea, vomiting, and severe dehydration. PEDV infects pigs of all ages, but neonatal pigs during the first week of life are highly susceptible; the mortality rates among n...

Full description

Bibliographic Details
Main Authors:	Techit Thavorasak, Monrat Chulanetra, Kittirat Glab-ampai, Kodchakorn Mahasongkram, Nawannaporn Sae-lim, Karsidete Teeranitayatarn, Thaweesak Songserm, Rungrueang Yodsheewan, Dachrit Nilubol, Wanpen Chaicumpa, Nitat Sookrung
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Microbiology
Subjects:	antibody-dependent enhancement enhancing epitope phage display technology phage panning phage mimotope porcine epidemic diarrhea
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.933249/full

Similar Items

Novel Neutralizing Epitope of PEDV S1 Protein Identified by IgM Monoclonal Antibody
by: Techit Thavorasak, et al.
Published: (2022-01-01)

Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase
by: Kittirat Glab-ampai, et al.
Published: (2022-07-01)

Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase
by: Kanasap Kaewchim, et al.
Published: (2021-10-01)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
by: Kanasap Kaewchim, et al.
Published: (2023-05-01)

Human Superantibodies to 3CL<sup>pro</sup> Inhibit Replication of SARS-CoV-2 across Variants
by: Kittirat Glab-ampai, et al.
Published: (2022-06-01)

Human super antibody to viral RNA-dependent RNA polymerase produced by a modified Sortase self-cleave-bacteria surface display system
by: Kantaphon Glab-ampai, et al.
Published: (2023-12-01)

Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. <i>Viruses</i> 2023, <i>15</i>, 1252
by: Kanasap Kaewchim, et al.
Published: (2023-09-01)

Bioinformatics Resources and Tools for Phage Display
by: Ping Dai, et al.
Published: (2011-01-01)

Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer
by: Kodchakorn Mahasongkram, et al.
Published: (2023-12-01)

Epitope mapping of mono- and polyclonal antibodies by screening phage-displayed random peptide libraries
by: Tomaž Bratkovič, et al.
Published: (2016-10-01)

Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy
by: Eduardo Antonio Ferraz Coelho, et al.
Published: (2015-08-01)

Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
by: Zhong Yanwei, et al.
Published: (2011-12-01)

Epitopes and Mimotopes Identification Using Phage Display for Vaccine Development against Infectious Pathogens
by: Marco Palma
Published: (2023-06-01)

Diagnostic Profiling of the Human Public IgM Repertoire With Scalable Mimotope Libraries
by: Anastas Pashov, et al.
Published: (2019-12-01)

PqsA mutation-mediated enhancement of phage-mediated combat against Pseudomonas aeruginosa
by: Qiao Su, et al.
Published: (2024-02-01)

In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success
by: Tea Glonti, et al.
Published: (2022-07-01)

Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia
by: Teagan L. Brown, et al.
Published: (2018-02-01)

MimoDB: a New Repository for Mimotope Data Derived from Phage Display Technology
by: Xianlong Wang, et al.
Published: (2010-11-01)

Efficacy of Individual Bacteriophages Does Not Predict Efficacy of Bacteriophage Cocktails for Control of Escherichia coli O157
by: Yan D. Niu, et al.
Published: (2021-02-01)

Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with <i>Leishmania amazonensis</i>
by: Tauane G. Soyer, et al.
Published: (2023-02-01)

The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era
by: Su Jin Jo, et al.
Published: (2023-09-01)

Restoring logic and data to phage-cures for infectious disease
by: Philip Serwer
Published: (2017-08-01)

Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development
by: Beata Zalewska-Piątek, et al.
Published: (2021-04-01)

The Israeli Phage Bank (IPB)
by: Ortal Yerushalmy, et al.
Published: (2020-05-01)

New Bacteriophages with Podoviridal Morphotypes Active against <i>Yersinia pestis</i>: Characterization and Application Potential
by: Tamar Suladze, et al.
Published: (2023-06-01)

The Battle between Bacteria and Bacteriophages: A Conundrum to Their Immune System
by: Addisu D. Teklemariam, et al.
Published: (2023-02-01)

Introducing a Novel, Broad Host Range Temperate Phage Family Infecting Rhizobium leguminosarum and Beyond
by: Sam Ford, et al.
Published: (2021-11-01)

Eco-Evolutionary Effects of Bacterial Cooperation on Phage Therapy: An Unknown Risk?
by: Adrián Cazares, et al.
Published: (2020-11-01)

Screening of sperm antigen epitopes by phage display technique and its preliminary clinical application
by: Jin-Chun Lu, et al.
Published: (2022-11-01)

Development of Real-Time Immuno-PCR Based on Phage Displayed an Anti-Idiotypic Nanobody for Quantitative Determination of Citrinin in <i>Monascus</i>
by: Wenping Huang, et al.
Published: (2019-09-01)

Novel peptides screened by phage display peptide library can mimic epitopes of the FnBPA‐A protein and induce protective immunity against Staphylococcus aureus in mice
by: Jin‐Nian Li, et al.
Published: (2019-10-01)

Factors affecting phage development and anti-phage defence systems in Staphylococcus aureus
by: Igor Eduardo Astudillo Skliarova
Published: (2022-11-01)

Do Anti-Phage Antibodies Persist after Phage Therapy? A Preliminary Report
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2022-10-01)

Advance on Engineering of Bacteriophages by Synthetic Biology
by: Sun Q, et al.
Published: (2023-03-01)

Characterization of Phage Resistance and Their Impacts on Bacterial Fitness in Pseudomonas aeruginosa
by: Na Li, et al.
Published: (2022-10-01)

Comparison of bacterial suppression by phage cocktails, dual‐receptor generalists, and coevolutionarily trained phages
by: Joshua M. Borin, et al.
Published: (2023-01-01)

Intestinal phages interact with bacteria and are involved in human diseases
by: Han Shuwen, et al.
Published: (2022-12-01)

Rekindling of a Masterful Precedent; Bacteriophage: Reappraisal and Future Pursuits
by: Israa M. Abd-Allah, et al.
Published: (2021-05-01)

Phage Therapy in Poland – a Centennial Journey to the First Ethically Approved Treatment Facility in Europe
by: Maciej Żaczek, et al.
Published: (2020-06-01)

Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
by: Thaysa Leite Tagliaferri, et al.
Published: (2019-02-01)